Tumour immunity

Show results for

Unknown (1218)
Transcriptomics (467)
Genomics (218)
Proteomics (55)
Metabolomics (13)
Other (8)
Models (2)
Clinical (2)
Methylation profiling (1)

Organisms

Mus musculus (246)
Homo sapiens (236)
Arabidopsis thaliana (9)
Sus scrofa (6)
Mustela putorius furo (5)
Bos taurus (5)
Rattus norvegicus (3)
Danio rerio (3)
Drosophila melanogaster (3)
Macaca mulatta (2)
Sparus aurata (2)
Schistosoma mansoni (2)
Oryctolagus cuniculus (2)
Vesicular stomatitis virus (1)
Amphimedon queenslandica (1)
Thermoplasma acidophilum DSM 1728 (1)
Danaus plexippus (1)
Capra hircus (1)
Dicentrarchus labrax (1)
Geranium pyrenaicum (1)
Locusta migratoria (1)
Macaca fascicularis (1)
Actinobacillus pleuropneumoniae (1)
Oryza sativa (1)
Oncorhynchus mykiss (1)
Solanum lycopersicum (1)
Ovis aries (1)
Caenorhabditis elegans (1)
Canis lupus familiaris (1)
Gallus gallus (1)

Organisms

Mus musculus (89)
Homo sapiens (49)
Muroidea (1)
Bacteria (1)
Drosophila melanogaster (1)

Repository

biostudies-arrayexpress (364)
ENA (174)
geo (129)
pride (35)
EGA (29)
MetaboLights (13)
iProX (9)
MassIVE (6)
jPOST (3)
BioModels (2)
PanoramaPublic (1)

Tissue

Cell culture (11)
Blood (4)
Epithelial cell (3)
Macrophage (3)
Primary cell (3)
Skin (3)
Bone marrow (2)
Brain (2)
Colon (2)
Fibroblast (2)
Hepatocyte (2)
Liver (2)
Melanocyte (2)
Spleen (2)
T cell (2)
B cell (1)
B-cell leukemia cell (1)
B-cell lymphoma cell (1)
B-lymphocyte (1)
Basophil (1)
Blood plasma (1)
Breast (1)
Cerebrospinal fluid (1)
Cerebrospinal fluid secretion (1)
Leukocyte (1)
Liver cancer cell (1)
Lung (1)
Lymph node (1)
Monocyte (1)
Permanent cell line cell (1)

Disease

Breast cancer (3)
Melanoma (3)
Brain cancer (2)
Colon cancer (2)
Liver cancer (2)
Skin cancer (1)
Cancer (1)
Tumor bearing (1)
Cutaneous melanoma (1)
Infected with Influenza A/WSN/33 (H1N1) (1)
Kaposi's sarcoma (1)
Rheumatoid arthritis (1)
Temporal lobe epilepsy (1)
No disease (1)
Prostate carcinoma (1)
Control (1)
Normal (1)
Carcinoma, Renal Cell (1)
Colorectal Neoplasms (1)
Burkitt lymphoma (1)
Chronic lymphocytic leukemia (1)
Chronic myeloid leukemia (1)
Disease free (1)
Female breast cancer (1)
Head and neck squamous cell carcinoma (1)
Hepatoblastoma (1)
Hepatocellular carcinoma (1)
Leukemia (1)
Lymphoma (1)
Skin melanoma (1)

Technology Type

Mass Spectrometry (35)
Shotgun proteomics (16)
Bottom-up proteomics (8)
Mass spectrometry assay (7)
Affinity purification coupled with mass spectrometry proteomics (7)
Mass spectrometry (6)
Data-dependent acquisition (5)
Data-independent acquisition (4)
SWATH MS (4)
ILLUMINA, Illumina HiSeq 2500 (2)
Affymetrix_SNP6_raw, Illumina HT 12, Agilent ncRNA 60k (1)

Instrument Platform

Illumina NovaSeq 6000 (16)
NextSeq 500 (11)
Illumina HiSeq 4000 (8)
Illumina HiSeq 2500 (7)
Illumina NovaSeq X (4)
DNBSEQ-T7 (3)
Illumina HiSeq 2000 (3)
BAS-5000 [FUJIFILM] (2)
Illumina Genome Analyzer II (2)
NextSeq 550 (2)
Orbitrap Eclipse (2)
Orbitrap Fusion Lumos (2)
GeneTitan Multi-Channel (MC) Instrument (1)
Agilent G2565BA Microarray Scanner System (Agilent Technologies, Santa Clara, CA) (1)
Tecan HS4800 hybridization station (Tecan, Vienna, Austria) (1)
Microbeads (1)
GeneChip Instrument System (1)
Affymetrix mouse gene 1.0 ST arrays (1)
Beckman Coulter MoFlo XDP (1)
Agilent Technologies SureScan Microarray Scanne (1)
Becton Dickinson INFLUX (1)
Affymetrix GeneChip Scanner 3000 7G (1)
BD Influx (1)
Agilent 2100 Bioanalyzer (1)
G2565AA DNA microarray scanner [Agilent] (1)
ScanArray Express HT [PerkinElmer] (1)
None (1)
NextSeq 2000 (1)
BGISEQ-500 (1)
6495C Triple Quadrupole LC/MS (1)

Publication Date

2026 (48)
2023 (45)
2025 (44)
2014 (44)
2013 (43)
2012 (40)
2024 (38)
2011 (36)
2010 (36)
2020 (23)
2015 (23)
2009 (21)
2021 (20)
2008 (19)
2016 (18)
2022 (14)
2019 (12)
2017 (10)
2018 (9)
2005 (8)
2007 (7)
2006 (3)
2004 (1)

UNIPROT ID/AC

P60568 (1)

CHEBI ID

CHEBI:58115 (2)
CHEBI:6650 (2)
CHEBI:16856 (2)
CHEBI:16865 (2)
CHEBI:15741 (2)
CHEBI:18012 (2)
CHEBI:176760 (1)
CHEBI:57746 (1)
CHEBI:58003 (1)
CHEBI:46960 (1)
CHEBI:233489 (1)
CHEBI:157672 (1)
CHEBI:456215 (1)
CHEBI:15801 (1)
CHEBI:25682 (1)
CHEBI:84520 (1)
CHEBI:49168 (1)
CHEBI:67040 (1)
CHEBI:57567 (1)
CHEBI:30830 (1)
CHEBI:157671 (1)
CHEBI:17141 (1)
CHEBI:28918 (1)
CHEBI:1547 (1)
CHEBI:41941 (1)
CHEBI:18307 (1)
CHEBI:17485 (1)
CHEBI:35619 (1)
CHEBI:17822 (1)
CHEBI:26271 (1)

Metabolite Name

Succinic acid (6)
Creatinine (6)
Citric acid (5)
D-Ribose 5-phosphate (5)
Uric acid (5)
Guanosine (5)
Inosine (5)
Histidine (4)
Leucine (4)
Uracil (4)
Pyroglutamic acid (4)
L-Aspartic acid (4)
Cerulenin (4)
Argininosuccinic acid (4)
6-Phosphogluconic acid (4)
Pyridoxine (4)
Choline (4)
Glycocholic acid (4)
Pantothenic acid (4)
Adenosine (4)
Histamine (4)
Threonine (4)
Proline (4)
Oleic acid (4)
Glycerol 3-phosphate (4)
Glutaric acid (4)
Glutamine (4)
Xanthine (4)
Trehalose (4)
Creatine (4)

First Public Date

2026 (38)
2023 (35)
2025 (34)
2024 (21)
2021 (13)
2014 (9)
2022 (8)
2019 (8)
2020 (4)
2018 (2)
2017 (1)
2016 (1)

Modelling Approach

Ordinary differential equation model (2)

Study status

Not provided (1)
Recruiting (1)

Lab affiliation

Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton 3800, VIC, Australia (2)
Deputy Head (Research), Department of Biochemistry and Molecular Biology Head Immunoproteomics Laboratory Infection and Immunity Program Room 214, level 2, 15 Innovation Walk Monash Biomedicine Discovery Institute Monash University, Clayton Campus Clayton 3800 Victoria Australia (2)
Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, University of Crete (2)
University of Oxford (2)
ABCT, The Hong Kong Polytechnic University (1)
CRUK - Beatson Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (1)
Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom (1)
Clinical and Experimental Sciences Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK Centre for Proteomic Research, Institute for Life Sciences, University of Southampton, Highfield Campus, Southampton, SO17 1BJ, UK (1)
Department of Molecular Biology, Princeton University, US (1)
Deputy Head (Research), Department of Biochemistry and Molecular Biology Head Immunoproteomics Laboratory Infection and Immunity Program Room 214, level 2, 15 Innovation Walk Monash Biomedicine Discovery Institute Monash University Clayton 3800 Victoria Australia (1)
Deputy Head (Research), Department of Biochemistry and Molecular Biology, Head Immunoproteomics Laboratory, Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Victoria, Australia (1)
Division Systems Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany (1)
Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, UK. DD1 9SY (1)
Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands; (1)
Faculty of Medicine, Pavol Jozef Šafárik University in Košice (1)
Head of Proteomics and Metabolomics Core Facility London Institute of Medical Sciences Medical Research Council (1)
Head of the Department, Proteomics Core Facility (1)
Institute for Advanced Research, Wenzhou Medical University, Wenzhou, Zhejiang, P.R. China. (1)
Karolinska Institutet, Department of Medicine Solna, Unit of Translational Immunology (1)
Krefting Research Centre, Institute of Medicine, University of Gothenburg, Sweden (1)
Laboratory for Mucosal Immunity, Center for Integrative Medical Sciences, RIKEN Yokohama Institute, Yokohama, Japan (1)
Laboratory for RNA Cancer Biology Department of Oncology, LKI, KU Leuven (1)
Prof. Sara Zanivan CRUK Beatson Institute Switchback road, Glasgow, UK G611BD (1)
Senior Postdoctoral Fellow Lew Laboratory Immunology Division The Walter and Eliza Hall Institute, Australia (1)
Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland; Agora Cancer Research Center, Lausanne, Switzerland; Division of Pulmonary Medicine, Department of Medicine, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland (1)
TDI Mass Spectrometry Laboratory, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK (1)
The Francis Crick Institute 1 Midland Road London NW1 1AT UK (1)
University of Calgary (1)
Wang Yiguang lab (1)
Weizmann Institute of Science (1)

Keyword

HRD deficient colorectal cancer (CRC) (1)
KEYTRUDA (pembrolizumab, MK-3475) (1)
Atezolizumab (1)
Olaparib (1)
Pembrolizumab (1)
Antibodies (1)

IsPrivate

False (2)

Submitter Keywords

Immuno-oncology (2)

Study type

Transcription profiling by array (261)
RNA-seq of coding RNA (39)
RNA-seq of coding RNA from single cells (18)
Transcription profiling by RT-PCR (5)
ChIP-seq (5)
Unknown experiment type (4)
Comparative genomic hybridization by array (4)
Methylation profiling by array (4)
RNA-seq of total RNA (3)
RNA-seq of non coding RNA (3)
RNA-seq of non coding RNA from single cells (2)
Animal - High-throughput sequencing (2)
Interventional (2)
Transcription profiling by SAGE (1)
Differential (1)
Animal - One-color microarray (1)
ChIP-chip by tiling array (1)
One-color microarray (1)
Human - High-throughput sequencing (1)
Transcription profiling by tiling array (1)
Genotyping by array (1)
Antigen profiling (1)
MicroRNA profiling by high throughput sequencing (1)
MicroRNA profiling by array (1)
DNA-seq (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2022 (181)
2023 (153)
2024 (147)
2025 (138)
2021 (126)
2020 (107)
2015 (78)
2017 (76)
2019 (72)
2016 (70)
2014 (68)
2018 (63)
2013 (56)
2012 (55)
2011 (45)
2010 (44)
2026 (26)
2009 (26)
2008 (21)
2007 (9)
2005 (9)
2006 (7)
2004 (3)
2003 (1)

Location

Spain (2)
France (1)

Previous page
1 / 199
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 199
Next page

Sort by:

Relevance

Page size

Mitochondrial respiration in B lymphocytes is essential for humoral immunity by controlling flux of the TCA cycle

To elucidate the function of oxidative phosphorylation (OxPhos) during B-cell differentiation we employ CD23Cre-driven expression of the dominant-negative K320E mutant of the mitochondrial helicase Twinkle (DNT). DNT-expression depletes mitochondrial DNA during B cell maturation, reduces the abun...

2026-08-21 | MTBLS4647 | MetaboLights

Low-Protein Diet Enhances Anti-Tumor Immunity in Pancreatic Cancer through Microbiota-Derived Uridine Diphosphate-Galactose

Low-protein diets (LPD) have been linked to improved metabolic health, but their role in pancreatic ductal adenocarcinoma (PDAC) immunotherapy remains unclear. Here we show that an LPD suppresses PDAC progression in male mice by remodeling the gut microbiota and activating anti-tumor immunity. LPD p...

2026-07-09 | MTBLS14989 | MetaboLights

PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity

PRJNA1471142 | ENA

Autophagy Suppresses CD8+ T cell Anti-tumour Immunity

PRJNA483127 | ENA

PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity

PRJNA1188580 | ENA

Interleukin-4 modulates type I interferon to augment anti-tumour immunity

PRJNA1224251 | ENA

TIM-3 restrains anti-tumour immunity by regulating inflammasome activation.

PRJNA637635 | ENA

The stress response regulator HSF1 modulates natural killer cell anti-tumour immunity